Mark Bachleda – Biography
Last update: March 9, 2026Executive profile
Mark was Chief Commercial Officer at Galera Therapeutics, and Vice President, United States Business Unit Head at Bristol Myers Squibb. Mark Bachleda joined Lyell Immunopharma in 2025.
Mark Bachleda is currentlyChief Executive Officer and Chairman of the Board at Eyconis - View - Eyconis org chart
Independent Director at Lyell Immunopharma - View - Lyell Immunopharma org chart
Create your alert
to follow the career of Mark Bachleda.
Education
Mark Bachleda has a Master of Business Administration from University of California, Berkeley - HAAS School of Business and a Master of Business Administration from Columbia University.
They have also studied at University of California, Berkeley - HAAS School of Business :
Find more alumni from University of California, Berkeley - HAAS School of Business
They have also studied at Columbia University :
Find more alumni from Columbia University
More about Mark Bachleda
Selected links
Do you need to know more about Mark Bachleda? More results.
Participate
Social media
- Mark Bachleda on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mark Bachleda
The colleagues of Mark Bachleda
Company Colleagues
- At Eyconis, Mark Bachleda has 19 colleagues including Garheng Kong (Director), Jan Møller Mikkelsen (Director)…
- At Lyell Immunopharma, Mark Bachleda has 26 colleagues including Lynn Seely (CEO & Director), Catherine Friedman (Director)…
Industry Colleagues
- In the Biotechnology industry, Mark Bachleda has 35,757 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Mark Bachleda.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Mark Bachleda.
